Final-Day Rush for Gujarat Kidney IPO as Demand Holds Firm Despite GMP Drop

Gujarat Kidney and Super Speciality’s IPO entered its final bidding session on December 24 with steady investor interest, even as grey market premium cooled sharply. The issue was subscribed about 3.80 times by mid-day, reflecting solid retail and non-institutional participation. Priced in a ₹108–₹114 band, the ₹250.8-crore IPO is a pure fresh issue of 2.2 crore shares. Proceeds are earmarked for expanding hospital capacity through acquisitions in Ahmedabad, a new Vadodara facility with robotic equipment, partial debt repayment, and future inorganic growth.